INS and type 2 diabetes mellitus: Since many type 2 diabetic patients exhibit elevated plasma levels of FFA and/or increased glucose levels, the underlying mechanisms for the deleterious action of long-term elevation of FFA on β-cells and glucose-induced insulin release would be highly important to elucidate.